Puberty Blockers Ban and the Controversial NHS Trial
The UK's ban on puberty blockers for gender dysphoria faces a new chapter as an NHS clinical trial is approved. Explore the debate on safety, ethics, and the future of youth gender care.
The UK's ban on puberty blockers for gender dysphoria faces a new chapter as an NHS clinical trial is approved. Explore the debate on safety, ethics, and the future of youth gender care.
In 1939, five-year-old Lina Medina became the world's youngest confirmed mother. Her extraordinary case remains one of medicine's greatest mysteries. Discover the untold story.
Controversial NHS trial will study effects of puberty blockers on children's brains. Professor Emily Simonoff says she's 'very proud' to lead landmark research amid legal threats.
NHS England initiates two clinical trials to assess the impact of puberty blockers on young people with gender incongruence, following the Cass review's findings of insufficient evidence.
NHS England launches two clinical trials investigating puberty blockers' effects on young people with gender incongruence. Findings expected in 4+ years following Cass review concerns.
The NHS is launching a controversial clinical trial, giving puberty blockers to 226 children as young as ten. Critics call it 'outrageous' while researchers insist on rigorous safety monitoring. Read the full story.
New Zealand halts new puberty blocker prescriptions for transgender youth, citing insufficient evidence. Critics warn of severe mental health impacts. Learn more about the global debate.
New Zealand halts new puberty blocker prescriptions for transgender youth, citing insufficient evidence. Critics warn of devastating mental health impacts. Read the full story.
A concerned mother shares her heartbreaking story about her teenage daughter being prescribed puberty blockers following brief NHS appointments, raising serious questions about youth gender care protocols.
After successfully overturning Queensland's controversial puberty blocker ban, a determined woman faces renewed battle as the LNP government reinstates the legislation, sparking fresh debates over transgender healthcare rights in Australia.
In a historic judgment with global implications, Australia's Federal Court has ruled that puberty blockers for transgender children are no longer considered 'therapeutic treatment', sparking intense debate across medical and LGBTQ+ communities.
In a groundbreaking healthcare policy shift, Queensland has suspended access to puberty blockers for transgender children, sparking a fierce court battle initiated by a determined mother fighting for her child's treatment.
A landmark court ruling declares Queensland's controversial puberty blocker ban unlawful, citing improper political influence and failure to consult medical experts in dramatic health policy showdown.
Exclusive: Labour supports NHS England's decision to halt routine puberty blocker prescriptions outside research settings, marking a significant shift in youth gender care policy.
New research highlights the often-overlooked struggles women face during menopause, calling for better awareness and healthcare support.
Discover how perimenopause, often dubbed 'second puberty', is gaining attention on TikTok, with women sharing their experiences and health experts weighing in.
New research suggests that aspartame, a common artificial sweetener found in Diet Coke, may trigger early puberty in children, raising health concerns among parents and experts.